Across TCGA pan-cancer cohorts, RNU6-905P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RNU6-905P data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher RNU6-905P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-905P expression acts as an unfavorable survival marker.

LIHC, MESO, and CESC are the cancer types where RNU6-905P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	II,III,IV	0.161	0.719	<.001	90	view →
MESO	OS	Tertile	IV	0.036	0.602	<.001	72	view →
CESC	OS	Tertile	II,III,IV	0.047	0.830	<.001	54	view →
LUSC	OS	Tertile	All	0.172	0.762	.002	36	view →
PAAD	OS	Tertile	All	0.060	0.641	<.001	36	view →
KIRP	DFS	Tertile	III,IV	0.191	0.720	.003	27	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	18	view →
THCA	DFS	Tertile	II,III,IV	0.082	0.762	<.001	18	view →
KIRC	DFS	Tertile	IV	0.127	0.630	.039	18	view →
PRAD	DFS	Tertile	All	0.399	0.937	<.001	18	view →
GBM	OS	Tertile	All	0.084	0.419	.001	9	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

Exploration

Same gene, other analysis: RNU6-905P tumor-vs-normal RNA expression · all RNU6-905P data types